Normal view MARC view ISBD view

Takimoto, Eiki

Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5. [electronic resource] - Circulation Apr 2007 - 2159-67 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

ISSN: 1524-4539

Standard No.: 10.1161/CIRCULATIONAHA.106.643536 doi

Subjects--Topical Terms:
3',5'-Cyclic-GMP Phosphodiesterases--antagonists & inhibitors
Animals
Atrial Natriuretic Factor--pharmacology
Cell Compartmentation--physiology
Cell Membrane--enzymology
Cells, Cultured--drug effects
Cyclic GMP--physiology
Cyclic GMP-Dependent Protein Kinases--antagonists & inhibitors
Cyclic Nucleotide Phosphodiesterases, Type 5
Cytosol--enzymology
Enzyme Activation--drug effects
Guanylate Cyclase--metabolism
Isoproterenol--pharmacology
Male
Mice
Mice, Inbred C57BL
Myocardial Contraction--drug effects
Myocytes, Cardiac--drug effects
NG-Nitroarginine Methyl Ester--pharmacology
Nitric Oxide--physiology
Phosphodiesterase Inhibitors--pharmacology
Piperazines--pharmacology
Protein Kinase Inhibitors--pharmacology
Purines--pharmacology
Receptors, Adrenergic, beta--drug effects
Second Messenger Systems--physiology
Sildenafil Citrate
Sulfones--pharmacology